Effects of a Decision Aid and Additional Decisional Counseling on Cardiac Risk Reduction Behavior and Health Outcomes

Similar documents
Preventive Cardiology

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Genetics and the prevention of CAD

Team members: Felix Krainski, Besiana Liti, William Lane Duvall (ASNC member)

Quality Payment Program: Cardiology Specialty Measure Set

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager

CHAPTER - III METHODOLOGY

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Preventive Cardiology Scientific evidence

Know Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital

for the Management of Chronic Disease

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiac rehabilitation: The psychological changes that predict health outcome and healthy behaviour

Patient-Centered Communication: A Strategy to Improve Patient Outcomes

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Clinical Trial Synopsis TL-OPI-518, NCT#

Supplementary Appendix

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Quality Payment Program: Cardiology Specialty Measure Set

Qualification Form Instructions

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Executive Summary Report Sample Executive Report Page 1

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

e-module Centers for Medicaid and Medicare (CMS) Core Measures

Cardiac Rehabilitation for Heart Failure Patients. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System

Supplement materials:

APPENDIX F: CASE REPORT FORM

Lack of documentation on overweight & obese status in patients admitted to the coronary care unit: Results from the CCU study

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

Cardiac CT Angiography

University of Toronto Rotation Specific Objectives. cardiac rehabilitation

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies

Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA

Cardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging

Cardiovascular Disease

Cardiac Rehabilitation The Evidence Base & Implications for Practice

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

A Systematic Approach to Improve Lipids in Coronary Artery Disease Patients Participating in a Cardiac Rehabilitation Program

SCIENTIFIC STUDY REPORT

Heart Disease. Signs and Symptoms

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Benefit of Performing PCI Based on FFR

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Heart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing

2013 Hypertension Measure Group Patient Visit Form

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

The Future of Cardiac Care: Managing Our Patients Together

2016 Internal Medicine Preferred Specialty Measure Set

Dr. Reginald Silver Dr. Antonis Stylianou Dr. Chandra Subramaniam. Patient Portal Usage: A Study of Antecedents and Patient Outcomes

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

The HeartQol questionnaire. Reliability, validity and responsiveness?

High Intensity Interval Exercise Training in Cardiac Rehabilitation

Cardiac Rehabilitation in the Outpatient Setting. Description

Mississippi Stroke Systems of Care

Standard emergency department care vs. admission to an observation unit for low-risk chest pain patients. A two-phase prospective cohort study

LIZ MIDENCE A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF

Quality Measures MIPS CV Specific

Integrated Next- Step Counseling

Consensus Core Set: Cardiovascular Measures Version 1.0

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Improving Vascular Health of Patients with Diabetes Mellitus

4. Which survey program does your facility use to get your program designated by the state?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Cindy McGeary, Ph.D., ABPP Associate Professor Clinical Psychology Training Director Department of Psychiatry

Protecting the heart and kidney: implications from the SHARP trial

South Bay Worksite Wellness. Health Coaching Report San Mateo County 2013 Health Coaching Program

Intercommunale de Santé Publique du Pays de Charleroi, Charleroi, Belgium 2

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Control Your Risk Factors

Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Community intervention programs to prevent cardiovascular disease

Depression, isolation, social support and cardiovascular rehabilitation in older adults

Treatment to reduce cardiovascular risk: multifactorial management

Acute Myocardial Infarction

Helping People Change

Women s Ischemia and cardiac rehabilitation

Cardiovascular Disease Prevention and Control: Mobile Health (mhealth) Interventions for Treatment Adherence among Newly Diagnosed Patients

Chapter 13: Principles of Adherence & Motivation. ACE Personal Trainer Manual Third Edition

Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND

Practice-Level Executive Summary Report

Cardiopulmonary Disease & Emotional Health Latasha Ellis, LCSW, OSW-C, RYT Licensed Counselor Iredell Health Systems

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

ACRA ASM /08/2017

Cardiovascular Concerns in Intermediate Care

NEW GUIDELINES FOR CHOLESTEROL

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Pharmacy Clinical Support Technician. Cardiac Sciences Program

Transcription:

Effects of a Decision Aid and Additional Decisional Counseling on Cardiac Risk Reduction Behavior and Health Outcomes Liv Wensaas, PhD a,rn, Cornelia M. Ruland, PhD, professor a,b, Shirley Moore, PhD, professor c a Center for Shared Decision Making, Oslo University Hospital, Oslo, Norway b Department of Medicine, University of Oslo, Norway c FPB School of Nursing, Case Western Reserve University, Cleveland, Ohio, USA

ACKNOWLEDGE Financial support for this study was provided by the South-Eastern Norway Regional Health Authority: Grant #: 3b-128 (2007-2009) The work was carried out at the Cardiac Outpatient Clinic in collaboration with Center for Shared Decision-Making and Collaborative Care Research, both at Oslo University Hospital, Rikshospitalet, Norway ClinicalTrials.gov Identifier: NCT00714935

BACKGROUND Coronary artery disease (CAD) is a pathological progression Palliative treatments; patients are still at increased risk for new cardiac events CAD is higly associated with modifiable risk factors Smoking Obesity Stress Lack of physical activity Healthy lifestyle will modify most risk factors for CAD progression

BACKGROUND Prevalence of non-adherence to proposed health recommendations is averaging 24.8 % (Di Matteo, 2004) So far interventions to produce lasting behavior change have shown limited effects (Ebrahim et al., 2006) Additional approaches to increase adherence to a healthy lifestyle are needed

BACKGROUND One promising approach developed to help patients to understand risks and treatment options are Decision Aids (DAs), a decision support system DAs differ because Specific Detailed Individualized focus on possible options and outcomes

Decision Aid (DA) -decision support There are DAs developed to help CAD patients (Lalonde et al., 2002) So far the effects of DAs in health behavior change interventions are sparse and inconclusive (Koelewijn-van Loon et al., 2009, 2010; Krones et al., 2008, 2010; Lalonde, et al., 2004, 2006; Lenz et al., 2009; Pignone et al., 2004; Sheridan et al., 2006, 2010b; van Steenkiste et al., 2007, 2008)

The DA in this study Developed by Ottawa Health Research Institute at Ottawa Hospital in collaboration with investigators from the Division of Clinical Epidemiology at Montreal General Hospital (Lalonde et al., 2002)

The DA-in this study Gjøre valg : Livsendringer for å redusere din risiko for hjertesykdom og hjerneslag Translated into Norwegian language Adjusted to Norwegian treatment recommendations in 2007 Et beslutningsstøtteverktøy for pasienter Lalonde, O Connor & Grover 2002

Often neglected in current DAs is that patients need: Help to prepare for making a choice Support to implement this choice in daily life activities

Counseling We developed an individual decisional counseling program (DCP) as a supplement to DA to help the patients to: Comprehend the information Adjust the information to personal illness story Elicit their preferences for cardiac risk reduction behavior Help them write a personal action plan. The effects of adding counseling to a DA for CAD patients have not been known

Decisional Counseling Program-DCP A multiple behavior change intervention based on the concepts in The Health Belief Model ( Eraker et al., 1984) Tailor Susceptibility and Severity of CAD Eliciting Benefits and Barriers Design a Preference-based behavior program

PURPOSE To evaluate the effects of a DA to assist cardiac patients in lifestyle changes with and without an additional individual decisional counseling program (DCP) on health outcomes and quality of life mediated by adherence to cardiac risk reduction behavior.

Design: METHODS Prospective, 3 group randomized, controlled trial with 4 repeated measures over the next 6 months Participants and setting: 363 patients > 18 years of age Referred to coronary angiogram

After completion of baseline measures patients were randomly assigned to study groups: DA group received the DA to take home DA+DCP group received the DA to take home and an appointment was set up for a home visit by the nurse counselor Control group

Variables and effects studied Independent variables Mediating variables Intermediated outcome Primary outcomes Primary outcomes DA DA+DCP Knowledge about risk factors and CAD Perceived susceptibility and severity of CAD or CAD progression, Perceived benefits and barriers to cardiac risk reduction behavior Adherence to cardiac risk reduction behavior Health outcomes HRQoL

Demographics Mean age 62.2 (10.1) years 38.3 % women 67.2 % married 71.6 % had no further education after secondary school 24 % smoking 56 % lack of physical activity

Sample 24.8 % previous myocardial infarction (MI) 20.7 % previous PCI 12.9 % previous CABG surgery Angiogram reveiled: 45.5 % no significant vessels disease Further treatment: 49.3 % medication only 23.1 % PCI 14.3 % CABG surgery 13.3 % no treatment

Group differences in health results 6 months following angiogram Health outcomes Control DA DA+DCP group group group M M M F Body Mass Index 27.41 27.20 26.95* 4.17 Total cholesterol 4.75 4.71 4.71 0.01 HDL 1.50 1.37 1.35 0.59 LDL 2.36 2.83 2.80 0.93 Systolic blood pressure 135 137 135 0.28 Diastolic blood pressure 78.38 79.02 81.69 1.70 Amount of tobacco in gram/week 51.72 53.83 48.16 0.09 p< 0.05 Note: The differences are adjusted for covariate = the baseline scores Alpha =.05.

HRQoL Group differences in HRQoL 6 months following angiogram Control group DA group DA+DCP group M M M F Physical Functioning 72.84 73.16 76.87 1.63 Role Functioning Physical 63.21 68.92 72.52* 3.93 Bodily Pain 61.82 63.41 64.18 0.29 General Health 57.44 59.67 63.50* 3.04 Vitality 48.56 51.70 55.89* 3.74 Social Functioning 76.65 75.16 78.95 0.95 Role Functioning Emotional 74.01 80.27 82.43* 3.49 Mental Health 72.39 75.44 76.88 2.38 Treatment Satisfaction 78.61 80.37 79.83 0.15 Disease Perception 65.85 70.27 75.91** 5.30 p< 0.05 **p< 0.01 Note: The differences are adjusted for covariate = the baseline scores Alpha =.05.

Group differences in adherence to risk reduction behavior 6 months following angiogram Control DA group DA+DCP group group Adherence M M M F Diet recommendations Activity recommendations 13.24 13.46 14.01 1.06 11.54 12.01 12.71 1.42 Stress reduction Taking medications 14.20 14.99 14.20 0.10 19.08 19.18 19.69 1.39 No smoking 19.10 19.08 19.06 0.01 Note: The differences are adjusted for covariate = the baseline scores Alpha =.05.

Group differences in mediating variables 2 months following angiogram Control group DA group DA+DCP group M M M F Knowledge about risk factors and CAD Perceived susceptibility of CAD or CAD progression Perceived severity of CAD or CAD progression Perceived benefits of cardiac risk reduction Perceived barriers to cardiac risk reduction 16.13 16.19 16.88 2.28 2.99 3.02 2.88 1.91 3.53 3.47 3.40 1.89 3.36 3.39 3.36 0.33 1.86 1.78 1.71* 3.94 p< 0.05 Note: The differences are adjusted for covariate = the baseline scores Alpha =.05.

LIMITATIONS Variations in the sample One of the interventions is rather expensive The nurse counselor was also the PhD student

CONTRIBUTION So far interventions to produce lasting behavior change have shown limited effects The two new interventions showed that information (DA alone) was not enough to make an impact To help patients to integrate information to their own life may be important No significant differences in adherence to cardiac risk reduction behavior

RECOMMENDATIONS Do not know the right "dose" of intervention, included structured system of reminders, selfevaluation, feedback and support Interesting to study the relative commitment from all the different ingredients in this complex intervention Need for replication Effectiveness Develope new approaches Develope interventions that are more costeffective, for example web-based application

CONCLUSION DA with the DCP showed some positive effects DA alone did not improve health behaviors and outcomes Do not know if these effects would have occurred by the DCP alone To tailor patients health beliefs and perceived barriers are important ingredients in this complex intervention.

THANK YOU FOR THE ATTENTION liv.wensaas@asker.kommune.no